Alliance

APH.L

Tags: GB Healthcare Drug Manufacturers - Specialty & Generic

Alliance Pharma plc Price (APH.L)

Stock Price

Low: Year Low

High: Year High

Market Cap

Fetching Data...

Enterprise Value

Fetching Data...

Shares Outstanding

540,144,706

(0.9419)%

Market Cap of Alliance (APH.L)

Market cap:

As of , APH.L has a market cap of . This makes APH.L the 451th most valuable company in the GB by market cap. Market capitalization, or market cap, is the total value of a company's outstanding shares of stock, calculated by multiplying the current stock price by the total number of shares.

Year

Beginning Of Year

End Of Year

YOY Change

Community Sentiment 0 votes

↑ 0% ↓ 0%

Description

Alliance Pharma plc operates as a pharmaceutical company in Europe, the Middle East, Africa, the Asia Pacific, China, and the Americas. The company acquires, markets, and distributes consumer healthcare and prescription medicine products. It holds the marketing rights of approximately 80 consumer healthcare and prescription medicine products. The company also offers medical devices, food supplements, and cosmetics. Alliance Pharma plc provides its products under the Aloclair, Anbesol, Asthon and Parsons, Atopiclair, Forceval, Hydromol, Kelo-cote, Macushi... Read More

Sector: Healthcare

Previous Close Fetching Data...
Range $24.55-66.2
Market Cap 346.50M
Enterprise Value No Data
Avg Volume Fetching Data...
P/E Ratio Fetching Data...
Dividend Yield Fetching Data...

Industry: Drug Manufacturers - Specialty & Generic

ceo: Mr. Nicholas John Sedgwick
IPO Date: November, 22, 2001
Country: GB
Currency: GBp
Headquaters: No Data
Employees: 290

- Revenue from each product or segment:

Product or Segment	Value:	% - Total	Last 3Y:

- Revenue by Region

Product or Segment	Value:	% - Total	Last 3Y: